secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2024-07-08T23:59:59+00:00
Accession:  0001140361-24-032559
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano raises $10M upfront via registered direct offering; adds $20M potential from milestone warrants
--------------------------------------------------------------------------------

- 17.5M shares/equivalents sold at $0.571/share for gross proceeds of ~$10M.
- Concurrent private placement includes Series A & B warrants exercisable at $0.571/share, offering up to $20M additional.
- Series A warrants expire 24 months post-stockholder approval or 60 days after MolDX coverage for optical genome mapping.
- Series B warrants expire 5 years post-approval or 6 months after FDA clearance for optical genome mapping system.
- Net proceeds earmarked for working capital, R&D, debt repayment, and capex; closing expected July 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124032559/0001140361-24-032559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124032559/ny20032138x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-032559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer